Board Member & Advisor

Life Sciences Executive | Board Advisor | Commercialization & Partnership Strategist | Biosecurity Leader

Expertise

Robert Morfino is a life sciences executive, board advisor, and commercialization strategist who brings deal discipline, technical fluency, and public sector market insight to boards, executive teams, and investment committees.

Commercialization Reality Testing

Determining whether a scientific asset has a genuine buyer, a workable price, and a repeatable sales motion before capital is committed to scale.

Public Sector Market Judgment

Assessing government procurement pathways, contracting cycles, and institutional buyer behavior that most commercial teams consistently underestimate.

Deal Structure Discipline

Evaluating partnerships, alliances, joint ventures, and acquisitions for value capture rather than announcement value or strategic optionality.

Technical Diligence Fluency

Reading the underlying science and engineering with enough depth to separate defensible platform advantage from well-presented incremental work.

Areas of Advisory

Growth Strategy & Market Entry

Aligning go-to-market approach, segment prioritization, and commercial roadmap with board expectations and durable value creation.

Corporate Development & M&A

Providing diligence perspective on acquisitions, joint ventures, alliances, and equity investments, informed by consulting and operator experience.

Government & Institutional Partnerships

Advising on public sector contracting, national program design, and the alignment of commercial strategy with policy and regulatory reality.

Technology Commercialization Oversight

Offering operator-level perspective on translating platform technology into pricing, packaging, and repeatable revenue architecture.

Boards ask whether the science works. The harder question, and the one that decides the company, is whether anyone will actually buy it.

Robert MorfinoLife sciences executive, Business Development Lead & Senior Director at Verily, former McKinsey Consultant, Harvard MBA.